Soleo Health has opened a new ambulatory infusion suite in the metro Denver area to complement its existing home infusion service offerings.

The Soleo Health Denver AIS, located at 9250 East Costilla Avenue, Suite 440, Greenwood Village, CO 80112, 303.968.1915, is ...

PORTLAND, OR, UNITED STATES, January 6, 2025 /EINPresswire / -- The global immunoglobulin market is experiencing significant growth, driven by the increasing prevalence of immune-related diseases and ...

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $25.19, but opened at $24.52. Immunovant shares last traded ...

Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) traded up 4.1% during mid-day trading on Tuesday . The company traded as high as $24.87 and last traded at $24.87. 67,350 shares traded hands during ...

Korean biotech firms anticipate significant developments in FDA approvals and clinical trials Innovations in medical research ...

Immune globulin (human) is under clinical development by Octapharma and currently in Phase III for Unspecified Neurologic Disorders.

Immune globulin (human) is under clinical development by CSL and currently in Phase III for Chronic Lymphocytic Leukemia (CLL).

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that argenx's VYVDURA (efgartigimod alfa and ...

Dutch immunology specialist argenx announced that Japan’s Ministry of Health, Labor and Welfare (MHLW) approved Vyvdura ...

Vyvdura receives Japanese regulatory approval for adults with chronic inflammatory demyelinating polyneuropathy: Rotterdam, the Netherlands Monday, December 30, 2024, 1 ...

European stock markets closed higher in Friday trading as the Stoxx Europe rose 0.67%, Germany's DAX gained 0.68%, the FTSE in London was up 0.16%, France's CAC climbed 1%, and the Swiss Market Index ...